Page last updated: 2024-08-21

dronabinol and Carcinoma, Ovarian Epithelial

dronabinol has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anil, SM; Belausov, E; Kendall, M; Koltai, H; Kumar, N; Peeri, H; Shalev, N; Tiwari, S; Vinayaka, AC	1

Other Studies

1 other study(ies) available for dronabinol and Carcinoma, Ovarian Epithelial

Article	Year
Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway. Molecules (Basel, Switzerland), 2022, Nov-03, Volume: 27, Issue:21 Topics: Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Ovarian Epithelial; Dronabinol; Female; Hallucinogens; Humans; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Wnt Signaling Pathway	2022

Article

Year

Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.

Molecules (Basel, Switzerland), 2022, Nov-03, Volume: 27, Issue:21

Topics: Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Ovarian Epithelial; Dronabinol; Female; Hallucinogens; Humans; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Wnt Signaling Pathway

2022